Complications and mortality after catheter ablation of ventricular arrhythmias

  • \(\bf Aims\) Catheter ablation of ventricular arrhythmias (VA) has proven to be an effective therapeutic option for secondary arrhythmia prophylaxis. We sought to assess the procedural efficacy, safety and in-hospital mortality of a large patient cohort with and without structural heart disease undergoing VA ablation. \(\bf Methods\) A total of 1417 patients (804 patients with structural heart disease) undergoing 1792 endo- and epicardial procedures were analyzed. Multivariable risk factor analysis for occurrence of major complications and intrahospital mortality was obtained and a score to allow preprocedural risk assessment for patients undergoing VA ablation procedures was established. \(\bf Results\) Major complication occurred in 4.4% of all procedures and significantly more often in patients with structural heart disease than in structurally normal hearts (6.0 vs. 1.8%). The frequency of these periprocedural complications was significantly different between procedures with sole right ventricular and a combination of RV and LV access (0.5 vs. 3.1%). The most common complication was cardiac tamponade in 46 cases (3.0%). Intrahospital death was observed in 32 patients (1.8%). Logistic regression model revealed presence of ischemic heart disease, epicardial ablation, presence of oral anticoagulation or dual antiplatelet therapy as independent risk factors for the occurrence of complications or intrahospital death, while a history of previous heart surgery was an independent predictor with a decreased risk. Based on this analysis a risk score incorporating 5 standard variables was established to predict the occurrence of complications and intrahospital mortality. \(\bf Conclusions\) Safety of VA catheter ablation mainly relies on patient baseline characteristics and the type of access into the ventricles or epicardial space.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Shibu MathewGND, Thomas FinkORCiDGND, Sebastian FeickertGND, Osamu InabaGND, Naotaka HashiguchiGND, Michael SchlüterGND, Peter WohlmuthGND, Erik WissnerGND, Roland Richard TilzGND, Christian‑Hendrik HeegerGND, Laura RottnerGND, Bruno ReißmannGND, Andreas RilligGND, Andreas MetznerGND, Tilman MaurerGND, Karl‑Heinz KuckGND, Feifan OuyangGND
URN:urn:nbn:de:hbz:294-99887
DOI:https://doi.org/10.1007/s00392-021-01902-2
Parent Title (English):Clinical research in cardiology
Subtitle (English):risk in VT ablation (RIVA) score
Publisher:Springer
Place of publication:Berlin
Document Type:Article
Language:English
Date of Publication (online):2023/06/22
Date of first Publication:2021/07/27
Publishing Institution:Ruhr-Universität Bochum, Universitätsbibliothek
Tag:Catheter ablation; Epicardial; Mortality; Risk score; Ventricular tachycardia
Volume:111
First Page:530
Last Page:540
Note:
Dieser Beitrag ist auf Grund des DEAL-Springer-Vertrages frei zugänglich.
Institutes/Facilities:Herz- und Diabeteszentrum NRW, Klinik für Elektrophysiologie/Rhythmologie
Herz- und Diabeteszentrum NRW, Diabeteszentrum
Dewey Decimal Classification:Technik, Medizin, angewandte Wissenschaften / Medizin, Gesundheit
open_access (DINI-Set):open_access
Licence (English):License LogoCreative Commons - CC BY 4.0 - Attribution 4.0 International